Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Factor XII

Coagulation

Coagulation Factor XIIFXIIHageman factor

Review status

Currently under review

Pending specialist review and validation.

What it shows

The Factor XII test measures the activity of Factor XII, a protein made by your liver that helps start the intrinsic pathway of blood clotting. It becomes active when blood comes into contact with certain surfaces, setting off a cascade that leads to clot formation in laboratory assays.

Your clinician may order this test when your activated partial thromboplastin time (aPTT) is prolonged, to determine whether the cause is a deficiency of this specific factor. Unlike some other clotting factor deficiencies, Factor XII deficiency typically does not cause abnormal bleeding. The test is performed on a blood sample collected in a citrate tube and is usually reported as activity relative to normal plasma.

Why it matters

Knowing your Factor XII activity helps clarify the reason for a prolonged aPTT and guides next steps in evaluation. A low result often points to a hereditary deficiency or an acquired reduction, while a normal result can redirect attention to other causes such as inhibitors or medications. This information helps avoid unnecessary treatments and supports accurate diagnosis.

This test is used with other studies, such as mixing studies and testing for other factors or inhibitors, to build a complete picture of your clotting system. While Factor XII deficiency is not linked to a bleeding tendency, it can affect how other tests look, which can be important before procedures or when evaluating unexplained lab results.

Understanding your results

If your Factor XII activity is low, your healthcare team will consider whether this reflects a lifelong, inherited condition or a temporary or acquired change. Many people with low Factor XII have no bleeding problems, and management often focuses on documenting the finding and understanding its impact on other tests. Your clinician may repeat testing, check other clotting factors, or perform mixing studies to confirm the result.

If your activity is higher than expected, it may reflect physiologic changes such as inflammation or hormone exposure. Your clinician will interpret the result in the context of your medications, medical history, and other coagulation tests. Follow-up depends on your overall clinical picture, not the lab number alone.

Reference ranges

0.71.4 unit/mL
All sexes
0 days – 150 years
0.71.4 U/mL
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Factor XII

  • Sample collection and tube fill

    Underfilled or overfilled citrate tubes, high hematocrit, or difficult draws can dilute or concentrate plasma and yield falsely low or high Factor XII activity.

  • Heparin and other anticoagulants

    Residual heparin from lines, unfractionated heparin therapy, or some direct oral anticoagulants can interfere with clot-based assays and mimic low activity.

  • Inflammation, hormones, and pregnancy

    Acute phase responses, estrogen therapy, and pregnancy can shift clotting factor levels and may modestly increase Factor XII activity.

  • Lupus anticoagulant and inhibitors

    Antiphospholipid antibodies and specific factor inhibitors can prolong clotting times and complicate interpretation of factor assays.

  • Liver function and severe illness

    Because Factor XII is made in the liver, significant liver disease, severe illness, or disseminated intravascular activation can alter measured activity.

  • Genetic deficiency and family history

    Inherited Factor XII deficiency is often detected after an unexpectedly prolonged aPTT and may be confirmed with repeat testing and family studies.

2026

References

  1. McGill University Health Centre. (2016, March 17). Factor XII (Task CD 18461606). Laboratory reference ranges.
  2. Keeling, D., Tait, R. C., & Makris, M. (2008). Guideline on the selection and use of tests of haemostasis. British Journal of Haematology, 141(3), 353–364.
  3. Favaloro, E. J., & Lippi, G. (2012). Preanalytical and analytical variables in coagulation testing. Seminars in Thrombosis and Hemostasis, 38(6), 571–582.
  4. Schmaier, A. H. (2016). The contact activation and kallikrein–kinin systems: Pathophysiologic and physiologic activities. Journal of Thrombosis and Haemostasis, 14(1), 28–39.